Flunixin Meglumine in stock

Superiority:

 

 

Flunixin meglumine       GMP complied manufacturer

 

 

best price  large production

Comply with  USP37/  EP8  /BPV2012

Highly quality and immedaite delivery

 

Package: 25.0KG NET DRUM

 

Main Uses: Mammalian anti-inflammatory analgesia, can alleviate muscle abnormalities caused by inflammation and pain, treatment of diarrhea, tremor, colitis, respiratory diseases, endotoxin-induced mastitis, arthritis, fever, diarrhea, tremor, eye infections, etc.           

 

 

 

Flunixin meglumine is a potent, non-narcotic, non-steroidal analgesic agent with anti-inflammatory and antipyretic activity. It is a potent inhibitor of the enzyme cyclooxygenase. It has demonstrated biological activity in the following areas:

• Analgesia (loss of pain). Flunixin meglumine demonstrated potent analgesic activity in laboratory studies with mice, rats, and monkeys. Parenterally, flunixin meglumine showed anti-writhing activity in mice equal to pentazocine and was more potent than meperidine and codeine. In the rat yeast paw test, it was significantly more potent than pentazocine, meperidine, and codeine. In monkeys, flunixin meglumine produced analgesia comparable to a clinically effective dose of morphine. In the horse, it has been shown to be an effective treatment of pain associated with colic. In contrast to narcotic agents, its analgesic effects were not antagonized by naloxone, tolerance did not develop, and cross-tolerance to codeine did not occur. These results show that flunixin meglumine is an effective analgesic in animals, and drug dependence liability does not occur.
• Anti-inflammatory. Flunixin meglumine showed anti-inflammatory activity in laboratory animals. A dose-related reduction in edema was recorded four hours after treatment. In the horse, anti-inflammatory activity was demonstrated in lameness models, showing relief of pain by improving stride length and reducing swelling.
• Potency. Based on manufacturers' recommendations in the horse, parenteral Banamine (flunixin meglumine), on a milligram per milligram basis, is four times as potent as phenylbutazone and twice as potent as ketoprofen. 

 

 

 

Product Name:  Flunixin Meglumine   

Chemical Name:  2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid meglumine salt

Formula/Structure: C₁₄H₁₁F₃N₂O₂^.C₇H₁₇NO₅         

Molecular Weight: 491.46        

CAS No.: 42461-84-7

                           

 

Chemwill Asia co.,Ltd is one of the leading GMP manufacturer of Veterinary and pharmaceutical products in CHINA. 

 

Our main production base is located in Xuzhou industry park. We produce a wide range of organics including Active pharmaceutical ingredients(APIs), Veterinary,  Indole derivatives, Aromatics, Fluorine, Boronic acids, organocatalysts, chiral building blocks, heterocyclic compounds. We are certified both to the ISO 9001 and ISO 14001 Standards, have a safety management system in place. 

 

Our R&D team masters core technology for process-design of target building block as well as Tailor-made fine chemicals. Our manufactory specialised in extreme temperature conditions (-100ºC to +300ºC), hydrogenations reaction under high pressure, suzuki coupling reaction, photochemical reaction, Mitsunobu reactions, enantioselective reactions and asymmetric synthesis. 

 

Think Chemistry,Think CHemWill

 

 

 

 

 

 

 

Factory Plant Address:
High-Tech Industrial park,Chemical Economical Development Zone,Xuzhou, Jiangsu-Province, P.R.China